imipenem, anhydrous has been researched along with Experimental Pneumococcal Meningitis in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 5 (62.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chahime, H; Guibert, M; Labrune, P; Odièvre, M; Petit, J | 1 |
| Diaz, E; Garcia-Curiel, A; Infante, P; Lopez, JD; Muñoz, M; Silva, JJ; Soult, JA; Valderrabanos, ES | 1 |
| González Bravo, N; Sánchez Bayle, M; Tamayo López, G | 1 |
| Asensi, F; Cabedo, JL; Cantón, E; Gresa, S; Otero, MC; Pérez-Tamarit, D; Rodríguez-Escribano, I | 1 |
| Benali, K; Bingen, E; Bonacorsi, S; Doit, C; Fitoussi, F; Geslin, P | 1 |
| Gouraud, F; Olivier, C | 1 |
| Abadia, C; Asensi, F; Cantó, E; Gallego, M; Llanes, S; Otero, MC; Pérez-Tamarit, D | 1 |
| Dworkin, RJ; Kennedy, SL; Sachdeva, M; Sande, MA; Tureen, JH | 1 |
8 other study(ies) available for imipenem, anhydrous and Experimental Pneumococcal Meningitis
| Article | Year |
|---|---|
Failure of cefotaxime treatment in two children with meningitis caused by highly penicillin-resistant Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Drug Therapy, Combination; Humans; Imipenem; Infant; Male; Meningitis, Pneumococcal; Penicillin Resistance; Rifampin; Streptococcus pneumoniae; Thienamycins | 1995 |
Appearance of resistance to beta-lactam antibiotics during therapy for Streptococcus pneumoniae meningitis.
Topics: beta-Lactam Resistance; Cefuroxime; Cephalosporins; Child; Humans; Imipenem; Male; Meningitis, Pneumococcal; Penicillins; Streptococcus pneumoniae; Vancomycin | 1995 |
[Treatment with imipenem-cilastatin in a girl with resistant pneumococcal meningitis].
Topics: Child, Preschool; Cilastatin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Imipenem; Meningitis, Pneumococcal; Streptococcus pneumoniae | 1993 |
Risk/benefit in the treatment of children with imipenem-cilastatin for meningitis caused by penicillin-resistant pneumococcus.
Topics: Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Humans; Imipenem; Infant; Meningitis, Pneumococcal; Penicillin Resistance; Risk Factors; Streptococcus pneumoniae | 1993 |
Comparative in vitro killing activities of meropenem, imipenem, ceftriaxone, and ceftriaxone plus vancomycin at clinically achievable cerebrospinal fluid concentrations against penicillin-resistant Streptococcus pneumoniae isolates from children with meni
Topics: Anti-Bacterial Agents; Carbapenems; Ceftriaxone; Cephalosporins; Child; Drug Therapy, Combination; Humans; Imipenem; Meningitis, Pneumococcal; Meropenem; Microbial Sensitivity Tests; Penicillin Resistance; Streptococcus pneumoniae; Thienamycins; Vancomycin | 1998 |
[Treatment of pneumococcal infections in children].
Topics: Ampicillin; Ampicillin Resistance; Cefotaxime; Drug Resistance, Microbial; Humans; Imipenem; Infant; Male; Meningitis, Pneumococcal; Streptococcus pneumoniae | 1989 |
Imipenem-cilastatin therapy in a child with meningitis caused by a multiply resistant pneumococcus.
Topics: Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Microbial; Female; Humans; Imipenem; Infant; Meningitis, Pneumococcal | 1989 |
Evaluation of FCE 22101 in experimental meningitis caused by Escherichia coli and Streptococcus pneumoniae.
Topics: Animals; Anti-Bacterial Agents; Blood Bactericidal Activity; Carbapenems; Ceftriaxone; Escherichia coli Infections; Imipenem; Meningitis; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Penicillins; Rabbits | 1989 |